Protein phosphorylation: In-charge and networking!

B. Kobe , J. Heierhorst , B. E. Kemp
Australian Biochemist 29 11 -13

1998
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase.

L. Misconi , S. M. Van Patten , Heung-Chin Cheng , B. E. Kemp
Journal of Biological Chemistry 261 ( 3) 989 -992

646
1986
Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products

B. E. Kemp , A. S. Mckenzie , D. A. Mcphee , B. J. Pollock
Clinical and Experimental Immunology 78 ( 3) 323 -328

8
1989
Phosphorylation of synthetic peptides of myosin light chains by skeletal muscle myosin light chain kinases

C. H. Michnoff , J. T. Stull , B. E. Kemp
Federation Proceedings 43 ( 6)

1984
Characterization of sheepbrain calcitonin receptors

P. M. Sexton , D. M. Findlay , B. E. Kemp , F. A.O. Mendelsohn
The 10th International Conference on calcium regulating hormones and bone metabolism 57 -63

1990
SUBSTRATE-SPECIFICITY OF A MULTIFUNCTIONAL CALMODULIN-DEPENDENT PROTEIN-KINASE

J. R. Woodgett , B. E. Kemp , R. B. Pearson , P. Cohen
Federation Proceedings 44 ( 3) 1718

11
1985
Spatial requirements for location of basic residues in peptide substrates for myosin kinase

B. E. Kemp , R. B. Pearson
Federation Proceedings 43 ( 7) 3096 -3096

1984
Effect of salt loading on expression and subcellular distribution of kidney AMP-activated protein kinase

D. A. Power , R. E. Hill , D. Stapleton , P. F. Mount
Journal of the American Society of Nephrology 14(Abstracts Issue) 141

2003
Regulatory and structural motifs of chicken gizzard myosin light chain kinase

N. J. Olson , R. B. Pearson , D. S. Needleman , M. Y. Hurwitz
Proceedings of the National Academy of Sciences of the United States of America 87 ( 6) 2284 -2288

178
1990
Localization of cofactor binding sites with monoclonal anti-idiotype antibodies: phenylalanine hydroxylase.

I. G. Jennings , B. E. Kemp , R. G. Cotton
Proceedings of the National Academy of Sciences of the United States of America 88 ( 13) 5734 -5738

34
1991
Structure and function of AMP-activated protein kinase.

J. S. Oakhill , J. W. Scott , B. E. Kemp
Acta Physiologica 196 ( 1) 3 -14

59
2009
β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK).

J. S. Oakhill , Z.-P. Chen , J. W. Scott , R. Steel
Proceedings of the National Academy of Sciences of the United States of America 107 ( 45) 19237 -19241

238
2010
Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans

Z.-P. Chen , T. J. Stephens , S. Murthy , B. J. Canny
Diabetes 52 ( 9) 2205 -2212

474
2003
Examination of ‘lipotoxicity’ in skeletal muscle of high‐fat fed and ob/ob mice

S. M. Turpin , J. G. Ryall , R. Southgate , I. Darby
The Journal of Physiology 587 ( 7) 1593 -1605

75
2009
High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation

B. G. Drew , N. H. Fidge , G. Gallon-Beaumier , B. E. Kemp
Proceedings of the National Academy of Sciences of the United States of America 101 ( 18) 6999 -7004

150
2004
Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity.

S. Beck Jørgensen , H. M. O’Neill , K. Hewitt , B. E. Kemp
Diabetologia 52 ( 11) 2395 -2404

37
2009
Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.

L. E. Brown , D. O. White , C. Agius , B. E. Kemp
Archives of Virology 140 ( 4) 635 -654

7
1995
Tissue-Specific Effects of Rosiglitazone and Exercise in the Treatment of Lipid-Induced Insulin Resistance

S. J. Lessard , D. A. Rivas , Z.-P. Chen , A. Bonen
Diabetes 56 ( 7) 1856 -1864

96
2007